Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

CreoSG Co Ltd (040350)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
935 -29    -3.01%
03/05 - Closed. Currency in KRW ( Disclaimer )
  • Volume: 1,726,658
  • Bid/Ask: 935 / 943
  • Day's Range: 881 - 970
Type:  Equity
Market:  South Korea
ISIN:  KR7040350001 
CreoSG 935 -29 -3.01%

CreoSG Company Profile

 
Read the CreoSG Co Ltd company profile to learn more about the business and the management team. View CreoSG Co Ltd facts about employee data, company products and services, and contact information.
IndustrySoftware & IT Services
SectorTechnology
Employees

33

Equity Type

ORD

CUROCOM Co., Ltd., together with its subsidiaries, develops software solutions for financial institutions in South Korea. It operates through Solution, Product Distribution, and New Drug and Vaccine Development divisions. The company offers bank automation and network control system for Korea (BANCS-K). It also provides IT outsourcing services, including information system development; ERP development and operation; sales system development and operation; vehicle management system development and operation; and operation of website and shopping mall integrated management systems. In addition, the company distributes IT products, such as LED monitors, TV monitors, solid-state drives, computers, laptops, and printers. Further, it engages in the development, production, and sales of infectious disease vaccines, therapeutic vaccines, and vaccines developed for alternative routes of administration. The company develops its products based on its VSV vector technology. Its product pipeline includes SAV001, a product candidate in Phase 1 clinical trials to treat HIV/AIDS; and product candidates in preclinical trials for the treatment of COVID-19, hepatitis C, Ebola virus, MERS virus, Zika virus, and SFTS/HFRS. CUROCOM Co., Ltd. was founded in 1997 and is headquartered in Seoul, South Korea.

Contact Information

Address Dongwon Building 4th Floor, 7 Teheran-ro 77-gil
Samseong-dong Gangnam-gu Seoul,
South Korea
Phone 82 2 2141 3000
Fax 82 2 2141 3097

Top Executives

Name Age Since Title
Jung-Gee Cho 54 2024 Full time Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

040350 Price Commentary

Write your thoughts about CreoSG Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email